Policy improves what beverages are served to young children in child care

Insights

California child care beverage policies led to significant improvements in healthy drink options for preschoolers. More sites offered water and limited sugary drinks, showing policy effectiveness.

Area of Science:

  • Public Health Nutrition
  • Childcare Policy
  • Health Behavior Research

Background:

  • A 2008 survey highlighted the need for improved beverage policies in California child care settings.
  • Federal (USDA) and state (California Healthy Beverages in Childcare) policies were implemented between 2011 and 2012 to regulate beverages served to children.
  • Policies mandated increased water availability, restricted sweetened beverages, and limited 100% juice servings.

Purpose of the Study:

  • To assess the impact of new state and federal beverage policies on drinks served in California child care.
  • To evaluate changes in beverage availability and types served before and after policy implementation.

Main Methods:

  • A statewide survey of licensed child care sites was conducted in 2008 and repeated in 2012.
  • A cross-sectional sample of approximately 1,400 child care sites was randomly selected and stratified by type.
  • Data from 429 sites in 2008 and 435 sites in 2012 were analyzed after adjusting for child care category.

Main Results:

  • Significant improvements were observed in 2012 compared to 2008, including increased water availability with meals/snacks (47% vs. 28%) and self-serve water access (77% vs. 69%).
  • Fewer sites served whole milk (9% vs. 22%) and limited 100% juice to once daily (20% vs. 27%).
  • In 2012, 60% of sites were aware of beverage policies, with 23% fully compliant with the California law.

Conclusions:

  • State and federal policies positively influenced beverage choices in child care settings.
  • Continued efforts are necessary to promote beverage policies and support their successful implementation in child care.
  • Further research and targeted interventions may be needed to increase policy awareness and compliance.
Abstract

Related Concept Videos

Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
998
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
941
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
543
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
394
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
398
Drug Regulation01:25

Drug Regulation

Drug regulation encompasses the management of drug usage by evaluating its safety and efficacy through assessments conducted by regulatory authorities. Regrettably, the history of drug regulation is marred by several catastrophic events. One such incident is the Elixir Sulfanilamide tragedy, in which the toxic compound diethyl glycol was included in a sweet-tasting medication, leading to numerous fatalities. This event prompted the enactment of the Food, Drug, and Cosmetic Act in 1938. Under...
2.9K